2642218-43-5
2642218-43-5
Chemical Structure
RIG012
- CAS No.: 2642218-43-5
- Formula:C23H21NO3
- Molecular Weight:359.42
IUPAC Name: 4-(benzyloxy)-3,3-diethyl-2H-benzo[g]indole-2,5(3H)-dione
InChIKey: OEWZCENSPLZNPQ-UHFFFAOYSA-N
SMILES: O=C1N=C2C3=C(C(C(OCC4=CC=CC=C4)=C2C1(CC)CC)=O)C=CC=C3
Biological Activity: RIG012 is a potent RIG-I inhibitor with an IC50 of 0.71 μM using the NADH-coupled ATPase assay. RIG012 inhibits IFN-β and ISG hRsad2 expression[1].
| Cat. No. | Product Name | Purity | Description | Pricing | |||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
|
RIG012 | 99.33% | RIG012 is a potent RIG-I inhibitor with an IC50 of 0.71 μM using the NADH-coupled ATPase assay. RIG012 inhibits IFN-β and ISG hRsad2 expression. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
RIG012 (Standard) | ≥98% | RIG012 (Standard) is the analytical standard of RIG012 (HY-147124). This product is intended for research and analytical applications. RIG012 is a potent RIG-I inhibitor with an IC50 of 0.71 μM using the NADH-coupled ATPase assay. RIG012 inhibits IFN-β and ISG hRsad2 expression. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
